We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Tenet (THC) Q1 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Tenet Healthcare (THC - Free Report) to post quarterly earnings of $4.21 per share in its upcoming report, which indicates a year-over-year decline of 3.4%. Revenues are expected to be $5.39 billion, up 3.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Tenet metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Net Operating revenues' at $5.37 billion. The estimate points to a change of +2.9% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net Operating revenues- Ambulatory Care' will likely reach $1.30 billion. The estimate indicates a change of +8.9% from the prior-year quarter.
Analysts forecast 'Net Operating revenues- Hospital Operations and Services' to reach $4.07 billion. The estimate suggests a change of +1.1% year over year.
It is projected by analysts that the 'Net patient service revenue per adjusted patient admission' will reach $18184.88 . The estimate is in contrast to the year-ago figure of $16335.00 .
Analysts' assessment points toward 'Net patient service revenue per adjusted patient admission' reaching $16970.44 . The estimate compares to the year-ago value of $16410.00 .
Analysts expect 'Adjusted patient admissions - Same-hospital' to come in at 212.31 thousand. Compared to the present estimate, the company reported 210.85 thousand in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted admissions' should come in at 208.48 thousand. Compared to the current estimate, the company reported 213.04 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Equity in earnings of unconsolidated affiliates' should arrive at $57.66 million. Compared to the current estimate, the company reported $56.00 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Adjusted EBITDA- Ambulatory Care' of $487.14 million. Compared to the current estimate, the company reported $456.00 million in the same quarter of the previous year.
The consensus estimate for 'Equity in earnings of unconsolidated affiliates- Ambulatory Care' stands at $55.55 million. Compared to the present estimate, the company reported $54.00 million in the same quarter last year.
Analysts predict that the 'Adjusted EBITDA- Hospital Operations and Services' will reach $622.37 million. The estimate compares to the year-ago value of $707.00 million.
Over the past month, Tenet shares have recorded returns of -5.8% versus the Zacks S&P 500 composite's +9.3% change. Based on its Zacks Rank #3 (Hold), THC will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Unveiling Tenet (THC) Q1 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts expect Tenet Healthcare (THC - Free Report) to post quarterly earnings of $4.21 per share in its upcoming report, which indicates a year-over-year decline of 3.4%. Revenues are expected to be $5.39 billion, up 3.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Tenet metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Net Operating revenues' at $5.37 billion. The estimate points to a change of +2.9% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net Operating revenues- Ambulatory Care' will likely reach $1.30 billion. The estimate indicates a change of +8.9% from the prior-year quarter.
Analysts forecast 'Net Operating revenues- Hospital Operations and Services' to reach $4.07 billion. The estimate suggests a change of +1.1% year over year.
It is projected by analysts that the 'Net patient service revenue per adjusted patient admission' will reach $18184.88 . The estimate is in contrast to the year-ago figure of $16335.00 .
Analysts' assessment points toward 'Net patient service revenue per adjusted patient admission' reaching $16970.44 . The estimate compares to the year-ago value of $16410.00 .
Analysts expect 'Adjusted patient admissions - Same-hospital' to come in at 212.31 thousand. Compared to the present estimate, the company reported 210.85 thousand in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted admissions' should come in at 208.48 thousand. Compared to the current estimate, the company reported 213.04 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Equity in earnings of unconsolidated affiliates' should arrive at $57.66 million. Compared to the current estimate, the company reported $56.00 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Adjusted EBITDA- Ambulatory Care' of $487.14 million. Compared to the current estimate, the company reported $456.00 million in the same quarter of the previous year.
The consensus estimate for 'Equity in earnings of unconsolidated affiliates- Ambulatory Care' stands at $55.55 million. Compared to the present estimate, the company reported $54.00 million in the same quarter last year.
Analysts predict that the 'Adjusted EBITDA- Hospital Operations and Services' will reach $622.37 million. The estimate compares to the year-ago value of $707.00 million.
View all Key Company Metrics for Tenet here>>>Over the past month, Tenet shares have recorded returns of -5.8% versus the Zacks S&P 500 composite's +9.3% change. Based on its Zacks Rank #3 (Hold), THC will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .